Pekka Kaipainen

558 total citations
14 papers, 408 citations indexed

About

Pekka Kaipainen is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Pekka Kaipainen has authored 14 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 6 papers in Pharmacology and 5 papers in Psychiatry and Mental health. Recurrent topics in Pekka Kaipainen's work include Pharmacological Effects and Toxicity Studies (6 papers), Epilepsy research and treatment (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Pekka Kaipainen is often cited by papers focused on Pharmacological Effects and Toxicity Studies (6 papers), Epilepsy research and treatment (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Pekka Kaipainen collaborates with scholars based in Finland, Poland and Thailand. Pekka Kaipainen's co-authors include Markku Partinen, Ismo Ilveskoski, Outi Saarenpää‐Heikkilä, Päivi Olsén, Turkka Kirjavainen, Miika Linna, Christer Hublin, Merimaaria Espo, Tiina Wallden and Pekka Nokelainen and has published in prestigious journals such as PLoS ONE, European Journal of Biochemistry and Biochemical Pharmacology.

In The Last Decade

Pekka Kaipainen

14 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pekka Kaipainen Finland	7	186	142	98	80	56	14	408
Ishani Landry United States	11	177 1.0×	173 1.2×	104 1.1×	26 0.3×	5 0.1×	26	317
Richard Gural United States	15	47 0.3×	42 0.3×	16 0.2×	22 0.3×	42 0.8×	23	430
Christian Keicher Germany	13	73 0.4×	56 0.4×	40 0.4×	144 1.8×	4 0.1×	21	634
Claire Mazuy France	9	38 0.2×	71 0.5×	83 0.8×	93 1.2×	12 0.2×	9	499
Danika C.A. Lyons Canada	9	43 0.2×	37 0.3×	64 0.7×	64 0.8×	7 0.1×	13	315
Marianne Rufiange Canada	12	100 0.5×	38 0.3×	101 1.0×	32 0.4×	3 0.1×	17	432
Grażyna Klupińska Poland	13	30 0.2×	46 0.3×	196 2.0×	38 0.5×	8 0.1×	40	517
Sanika Chirwa United States	11	67 0.4×	10 0.1×	19 0.2×	24 0.3×	109 1.9×	23	462
D.D. Hagerman United States	10	54 0.3×	48 0.3×	193 2.0×	25 0.3×	22 0.4×	18	511
Valentina Castelli Italy	15	33 0.2×	13 0.1×	34 0.3×	59 0.7×	5 0.1×	40	589

Countries citing papers authored by Pekka Kaipainen

Since Specialization

Citations

This map shows the geographic impact of Pekka Kaipainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pekka Kaipainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pekka Kaipainen more than expected).

Fields of papers citing papers by Pekka Kaipainen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pekka Kaipainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pekka Kaipainen. The network helps show where Pekka Kaipainen may publish in the future.

Co-authorship network of co-authors of Pekka Kaipainen

This figure shows the co-authorship network connecting the top 25 collaborators of Pekka Kaipainen. A scholar is included among the top collaborators of Pekka Kaipainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pekka Kaipainen. Pekka Kaipainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Zagrodzki, Paweł, et al.. (2016). Does valproate therapy in epileptic patients contribute to changing atherosclerosis risk factors? The role of lipids and free fatty acids. Pharmacological Reports. 68(6). 1339–1344. 9 indexed citations

Zagrodzki, Paweł, Fergus Nicol, H. Bartoń, et al.. (2013). Antioxidant agents and physiological responses in adult epileptic patients treated with lamotrigine. Pharmacological Reports. 65(1). 99–106. 10 indexed citations

Partinen, Markku, Outi Saarenpää‐Heikkilä, Ismo Ilveskoski, et al.. (2012). Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland. PLoS ONE. 7(3). e33723–e33723. 286 indexed citations

Zagrodzki, Paweł, Joanna Chłopicka, H. Bartoń, et al.. (2011). Valproic Acid Modulates Superoxide Dismutase, Uric Acid-Independent FRAP and Zinc in Blood of Adult Epileptic Patients. Biological Trace Element Research. 143(3). 1424–1434. 14 indexed citations

Ounjaijean, Sakaewan, T. Westermarck, Markku Partinen, et al.. (2011). Increase in non-transferrin bound iron and the oxidative stress status in epilepsy patients treated using valproic acid monotherapy. International Journal of Clinical Pharmacology and Therapeutics. 49(4). 268–276. 17 indexed citations

Kaipainen, Pekka, T. Westermarck, Markus Kaski, M. Iivanainen, & Faik Atroshi. (2006). Determination of levetiracetam in patients with epilepsy and intellectual disability. Epilepsia. 47. 133–133. 1 indexed citations

Laakso, Minna, et al.. (2005). Urinary 6‐hydroxymelatonin sulfate excretion in intellectually disabled subjects with sleep disorders and multiple medications: Validation of measurements in urine extracted from diapers. Scandinavian Journal of Clinical and Laboratory Investigation. 65(5). 413–432. 3 indexed citations

Westermarck, Tuomas, et al.. (2005). Effects Of Dietary Supplemetation With Ginger Extract In Osteoarthritis. A Double-blind Controlled Study. Therapeutic Drug Monitoring. 27(2). 259–259. 5 indexed citations

Atroshi, Faik, Pekka Kaipainen, & J. Parantainen. (1987). Evidence for the presence of cytochrome P-450 in mastitic bovine mammary gland. Pharmacological Research Communications. 19(10). 673–678. 3 indexed citations

10.

Juvonen, Risto O., Pekka Kaipainen, Otto Hänninen, & M. Lang. (1986). Coumarin 7-Hydroxylase in Inbred Strains of Mice: Comparison with Other Microsomal Monooxygenase Activities and Induction by Pyrazole. Archives of toxicology. Supplement. 9. 367–370. 5 indexed citations

11.

Kaipainen, Pekka & M. Lang. (1985). Comparison of kidney, lung and liver coumarin 7-hydroxylases in phenobarbital pretreated DBA/2J and C57BL/6J mice. Biochemical Pharmacology. 34(11). 1987–1991. 6 indexed citations

12.

Kaipainen, Pekka, et al.. (1985). Inhibition by Methylglyoxal bis(guanylhydrazone) of Drug Oxidation Reactions Catalyzed by Mouse Liver Microsomes in Vivo and in Vitro. Acta Pharmacologica et Toxicologica. 57(4). 250–254. 1 indexed citations

13.

Kaipainen, Pekka, Ulla Koivusaari, & Matti A. Lang. (1985). Catalytic and immunological comparison of coumarin 7-hydroxylation in different species. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 81(2). 293–296. 19 indexed citations

14.

Kaipainen, Pekka, Daniel W. Nebert, & Matti A. Lang. (1984). Purification and characterization of a microsomal cytochrome P-450 with high activity of coumarin 7-hydroxylase from mouse lives. European Journal of Biochemistry. 144(3). 425–431. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact